27 related articles for article (PubMed ID: 7954459)
1. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
2. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.
Olson OC; Joyce JA
Nat Rev Cancer; 2015 Dec; 15(12):712-29. PubMed ID: 26597527
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B and Cathepsin D Expression in Follicular Adenomas and Carcinomas of the Thyroid Gland.
Ruhoy SM; Clarke MR
Endocr Pathol; 1997; 8(1):49-57. PubMed ID: 12114671
[TBL] [Abstract][Full Text] [Related]
4. The Expression of Lysosomal Proteinases and Their Inhibitors in Breast Cancer: Possible Relationship to Prognosis of the Disease.
Lah TT; Kos J; Blejec A; Frkovic-Georgio S; Golouh R; Vrhovec I; Turk V
Pathol Oncol Res; 1997; 3(2):89-99. PubMed ID: 11173633
[TBL] [Abstract][Full Text] [Related]
5. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
[TBL] [Abstract][Full Text] [Related]
6. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma.
Hughes SJ; Glover TW; Zhu XX; Kuick R; Thoraval D; Orringer MB; Beer DG; Hanash S
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12410-5. PubMed ID: 9770500
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B.
Van Noorden CJ; Jonges TG; Van Marle J; Bissell ER; Griffini P; Jans M; Snel J; Smith RE
Clin Exp Metastasis; 1998 Feb; 16(2):159-67. PubMed ID: 9514097
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Werle B; Jülke B; Lah T; Spiess E; Ebert W
Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.
Kasper M; Lackie P; Haase M; Schuh D; Müller M
Virchows Arch; 1996 Jul; 428(4-5):207-15. PubMed ID: 8764928
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer.
Khan A; Krishna M; Baker SP; Malhothra R; Banner BF
Arch Pathol Lab Med; 1998 Feb; 122(2):172-7. PubMed ID: 9499362
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
Inoue T; Ishida T; Sugio K; Sugimachi K
Cancer Res; 1994 Dec; 54(23):6133-6. PubMed ID: 7954459
[TBL] [Abstract][Full Text] [Related]
16. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
Mori M; Kohli A; Baker SP; Savas L; Fraire AE
Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
